Monday 28 September 2015

Increased Mobility for Higher Life Expectancy to Drive Global Orthopedic Devices Market

The rise in aging population and sports and road injuries, coupled with increasing demand for minimally-invasive surgeries has spurred the growth of the global orthopedic devices market, according to a new report published by Transparency Market Research. The report, titled “Orthopedic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, indicates that registering a 4.9% CAGR from 2013 to 2019, the worldwide market for orthopedic devices is likely to develop from US$29.2 billion in 2012 to US$41.2 billion by 2019.On the basis of anatomical location, the market for orthopedic devices is segmented into knee, hip, elbow, shoulder, spine, foot and ankle, craniomaxillofacial, and other extremities. Each of these locations are further fragmented into internal fixation devices, joint implants, and external fixation devices. By anatomical location, knees dominated the overall market in terms of revenue. However, this segment is forecast to witness a slight drop in market share by 2019 owing to frequent product recalls.
Hip orthopedic devices also held the a major share of the overall market in 2012 and are projected to register a CAGR of 5.9% from 2013 to 2019 owing to increasing incidence of hip fractures, rise in aging population, and growing demand for hip replacement surgeries. Among the major orthopedic consumables, namely orthopedic suture anchors and orthopedic staples, anchors held the largest share of the market. This segment comprises metallic suture anchors and resorbable suture anchors and held 80% of the orthopedic consumables market in 2012. The market value of orthopedic consumables is estimated to be US$457 million by 2019.
The geographic segmentation of the global orthopedic devices market includes four main regions: North America, Europe, Asia Pacific, and Rest of the World. North America has emerged as the leader of the worldwide market and is projected to retain its dominant position through 2019. The U.S. orthopedic devices market is driven by increasing cases of obesity and osteoarthritis, growing use of bioabsorbable implants, and rise in geriatric population. Europe, the second-largest market for orthopedic devices in the world, is fueled by growing demand for drug-eluding stents and infusion pumps. Asia Pacific, however, has been identified as the fastest developing regional market for orthopedic devices, driven largely by rapid industrialization and surge in population.
The competitive landscape of the orthopedic devices market is immensely consolidated. The major players profiled in the global orthopedic devices market report are Wright Medical Technology, Inc., aap Implantate AG, Vilex, Inc., Aesculap, Inc., Integra LifeSciences, Zimmer Holdings, Inc., DePuy Synthes, Inc., Stryker Corporation, ArthroCare Corporation, Smith & Nephew PLC, Solana Surgical LLC, Conmed Corporation, Globus Medical, Inc., TriMed, Inc., Orthofix Holdings, Inc., NuVasive, Inc., Arthrex, Inc., Small Bone Innovations, Inc., Medtronic, Inc., and Biomet, Inc. The orthopedic devices market for hip and knee surgeries is dominated by Depuy Synthes, Zimmer, and Stryker, while the market for spinal surgeries is led by NuVasive, Depuy, Stryker, and Medtronic.
Browse the full Orthopedic Devices Market (Hip, Knee, Spine, Shoulder, Elbow, Foot and Ankle, Craniomaxillofacial and Other Extremities) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Press Release at http://www.transparencymarketresearch.com/pressrelease/orthopedic-devices-market.htm

Global Dental Equipment Market Trends 2015

Transparency Market Research, a market intelligence company based in the U.S., has announced the release of a study on the dental equipment market. The report finds that the global dental equipment market was worth approximately US$5415 million in 2014, and will likely surge to US$7140 million by the end of 2019. The report is titled 'Dental Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018.' This comprehensive report drills down to the third level of the dental equipment market to throw light on key aspects such as emerging product segments, consumer trends and their impact, types of dental ailments and the resultant demand for diagnosis and treatment, and more.
According to the findings of the report, growth in the dental equipment market is stimulated by new developments in treatment procedures as well as the advent of novel technologies that make dental treatments less painful and more effective. Moreover, the role of dentistry in aesthetic and cosmetic procedures is rising. This has broadened the overall consumer base of the dental equipment market. As a result, from largely constituting people suffering from dental problems to a few years ago, a major share of market revenue is now also coming from consumers looking for cosmetic enhancements.
The report segments and analyzes the global dental equipment market on the basis of product type and geographical region. By product, the dental equipment market is split into six categories, namely: systems and parts, laboratory machines, dental lasers, hygiene maintenance, dental radiology equipment, and others.
At the beginning of the forecast period, the systems and parts market held the largest share within the dental equipment market. This can be attributed to the fact that equipment parts and systems are integral to virtually every other segment within this market. Dental lasers, a relatively new concept for treating diseases of the teeth and gums, were observed as being the smallest segment within the global dental equipment market. However, as is the case with many other fields, the use of lasers will also gather pace in dentistry and dentists will increasingly adopt laser treatment procedures. With this, the dental lasers segment is predicted to be the fastest growing within the global dental equipment market.
From the geographical standpoint, the high prevalence of diseases of the teeth and gums in North America puts this region in a leading position within the market. North America has the highest incidence of dental caries, creating vast demand for treatment procedures. On the other hand, regions such as Asia Pacific will not show the same level of growth potential as that of North America and Europe. The key restraining factors for the growth of the dental equipment market in Asia Pacific are the high cost of specialized dental treatments and a slow rate of adoption of advanced techniques. These restraints are further compounded by the general lack of awareness about the latest dental treatment procedures among patients in the Asia Pacific market.
Browse the full Dental Equipment Market (Dental Extraoral & Intraoral Radiology, Dental Lasers, Cone Beam CT Systems, Laboratory Machines, Hygiene Maintenance Devices, Chairs and Light Cure Equipment) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 Press Release at http://www.transparencymarketresearch.com/pressrelease/dental-devices-market.htm
This report by TMR also profiles prominent players in the global dental equipment market, such as: Straumann, Noble Biocare, 3M ESPE, A- Dec Inc., Biolase Inc, Sirona Dental Systems Inc., Danaher Corporation, Midmark Corporation, Henry Schein, Inc., and others 

Global Clinical Laboratory Services Market - Market Trends, Types, Demand Patterns, and Key Players

Transparency Market Research announces the release of a new market research report on the global market for clinical laboratory services. The report provides an executive-level overview of the market and equips market players with crucial information about the market. It employs various reliable analytical tools to present a comprehensive examination of the market. Results of the Porter’s Five Forces Analysis present the dynamics between the supplier and the buyer, and established and new market players; impact analysis presents a precise analysis of the effect influential factors will have on the growth of the market; and market attractiveness analysis provides insightful information to potential investors.
The report, compiled by experienced industry experts, is titled ‘Clinical Laboratory Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’. According to the comprehensive analysis presented in the report, the global clinical services market is expected to grow at a CAGR of 5.8% upon its 2012 valuation of US$162.71 billion to reach a value of US$241.37 billion in 2019.The report divides the global clinical laboratory services market according to test type, service provider, and geography. Each of the segmentations is carefully analyzed to present the market hierarchy with regard to the particular criterion and growth prospects of each category.
By test type, the clinical laboratory services market is divided into clinical chemistry, medical microbiology and cytology, human and tumor genetics, and other esoteric tests. Due to the rising incidence of diseases such as cancer and diabetes, the demand for these tests is expected to rise at a steady rate. The convenience, precision, and efficiency offered by these diagnostic tests is also a major growth driver for the market. The increasing global geriatric population, which is more prone to diseases requiring these tests, is also a major driver for the clinical laboratory services market.
Rising geriatric population also has a role to play in the geographical breakdown of the clinical laboratory services market. North America, of whose population 20% is expected to be geriatric by 2030, is a dominant market leader in the global clinical laboratory services market and is expected to retain the domination through the forecast period. The growing pool of geriatric citizens in Asia Pacific will help the regional market grow at a rapid rate, though not enough to upstage the North America market. Other geographical segments of the global clinical laboratory services market are Europe and the Rest of the World.A major restraint acting on the clinical laboratory services market is the inconsistency in regulations governing the market in various regions of the world and the convoluted approval procedures for new products.
Browse the full Clinical Laboratory Services Market (Clinical Chemistry, Medical Microbiology & Cytology, Human & Tumor Genetics and Other Esoteric Tests) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Press Release at http://www.transparencymarketresearch.com/pressrelease/clinical-laboratory-services-market.htm
The report also examines the market’s key players, facilitating a comprehensive understanding of the market’s competitive landscape and helping the formulation of informed market strategies with a higher probability of success. The report performs a financial overview and examines the product catalog, business strategies, and recent developments of major market players such as ARUP Laboratories, Abbott Laboratories, Charles River Laboratories, Bioscientia Healthcare, Genoptix Genoptix Medical Laboratory, and Healthscope Ltd.

Global Teleradiology Market: Mobile Health Services to Help Market Growth During 2013-2019

The global teleradiology market was worth US$0.92 billion in 2012. It has been predicted that this market will grow at a CAGR of 22.3% from 2013 to 2019, eventually reaching an estimated market value of US$3.78 billion. These projections are provided in a market research report titled Teleradiology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019, released by market intelligence firm Transparency Market Research.
The report details the important historical benchmarks of the global teleradiology market and the driving and restraining factors that govern it.
It states the teleradiology segment to be the largest source of revenue for the telehealth technologies industry.
The teleradiology market involves the technology that deals in the transmission of radiography images from external or remote locations to a strong healthcare establishment in an urban area though software that make use of the Internet. It is the largest and the most mature segment of the telehealth industry and makes use of advanced communication technology in an effort to exchange critical information about a patient in the most efficient manner possible.
The report discusses a comparative overview of the global teleradiology market with respect to the past and the present. Earlier communication systems would convert analog images into digital ones through the use of binary code. The code was then forwarded to a receiving terminal where the data was again converted to analog. Modern methods circumvent this need of conversion thereby saving time and maintaining imaging efficacy.
The report also includes important developments in the global teleradiology market, such as the advent of Radiology Information Systems (RIS) and Picture Archiving and Communication Systems (PACS). These technologies have created a substantial increase in demand of teleradiology services and technologies around the world. The growth of the global teleradiology market along with the increasing use of high bandwidth broadband systems have created a high level of efficiency and assurance across remote channels of the healthcare industry.
The increasing popularity and growing applications in the mobile health segment of the global teleradiology market has allowed radiologists to boost their diagnosis and consultation speeds by letting them do so even while commuting. This has eliminated the requirement of a doctor to access stationary computer terminals for consultations that can be performed using mobile devices.
Browse the full Teleradiology Market (X-ray, Ultrasound, CT, MRI and Nuclear Imaging) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 Press Release at http://www.transparencymarketresearch.com/pressrelease/teleradiology-technology-market.htm
The report details the geographic segmentation of the global teleradiology market. It states that North America dominated the global teleradiology market in 2012 with more than 33% of the market share in terms of revenue. This was possible due to the presence of healthcare institutions that possess eligible equipment along with a growing acceptance and knowledge of the public with respect to the technologies.

Global Negative Pressure Wound Therapy Market: an Overview

A new report has been published by Transparency Market Research, titled “Negative Pressure Wound Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”. TMR, a market intelligence company based in the U.S., states in its report that the global negative pressure wound therapy market was estimated at US$1.5 billion in 2013 and, growing at a remarkable CAGR of 10.2% from 2014 to 2020, is predicted to reach US$2.9 billion in 2020.The TMR report states that negative pressure wound therapy (NPWT) is a leading wound care therapy, which applies negative or sub-atmospheric pressure on a wound in a closed drainage system. Negative pressure wound therapy aides wound healing by stimulating the granulation tissue, by lowering edema, and increasing blood circulation. NPWT systems can be utilized for treating traumatic wounds, surgical wounds, pressure sores, and chronic wounds such as venous stasis ulcers and diabetic foot ulcers.
The study states that based on the type of devices, negative pressure wound therapy systems are segmented into single use NPWT systems and conventional NPWT systems. In terms of disposables, the conventional NPWT systems are further segmented into pumps, canisters, and dressing kits. Additionally, NPWT systems can also be utilized for treating injuries such as meshed skin grafts and burns.As per this report, in terms of product segments, conventional negative pressure wound therapy systems constituted the biggest market segment, but the single use NPWT systems market segment is expanding at a higher CAGR – of about 17 % – during the forecast horizon between 2014 and 2020. The negative pressure wound therapy market is experiencing a conspicuous shift from utilization of conventional NPWT systems to single use NPWT systems. This shift in inclination is majorly due to the higher convenience offered by single use NPWT systems to patients, as well as their cost advantage over conventional systems and higher portability.
The report states that the key factors contributing to the expansion of this market are the rising global geriatric population and rising incidence of chronic diseases such as diabetes and cancer. Moreover, increased awareness on advanced wound care devices is also stimulating the growth of this market. However, increase in healthcare expenditure as well as fluctuating economic conditions have resulted in hampered growth prospects for the global NPWT market.As per this TMR research report, the market is segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is the biggest market for NPWT systems due to supportive reimbursement policies. Europe represents the second biggest market for NPWT systems owing to high occurrence rate of transit accidents. Asia Pacific is predicted to witness the highest growth owing to robust economic development, increasingly favorable government policies, and increase in demand for technologically developed wound care products.
Browse the full Negative Pressure Wound Therapy Market (Conventional and Single Use NPWT Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 Press Release at http://www.transparencymarketresearch.com/pressrelease/negative-pressure-wound-therapy.htm
Devon Medical, Inc., ConvaTec, Inc., Inc., Prospera Technologies LLC, Molnlycke Health Care AB, Smith & Nephew plc and Spiracur, Inc., and Kinetic Concepts are the major players in the global negative pressure wound therapy market.

Global Ambulance Services Market : Increasing Number of Emergency Cases Remains Primary Growth Driver

A recently released report from Transparency Market Research (TMR) forecasts that the global ambulance services market will grow at a CAGR of 8.3% between 2013 and 2019. TMR, a market intelligence firm based in the U.S., states that the global ambulance services market will reach a market value of US$29.78 billion by 2019, from US$17 billion in 2012.The report, titled ‘Ambulance Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, is available for sale on the company website. According to this market research report, rising geriatric population, favorable reimbursement policies, rising incidence of accidents, and increasing prevalence of diseases such as cancer and diabetes are a few of the factors that stimulate the global ambulance services market. The introduction of new ambulances also plays a significant role in determining demand from this market. It is expected that the entry of new ambulance service providers, a favorable and organized reimbursement scenario, and greater home healthcare will propel the demand for ambulance services in the years to come.
This TMR report segments the global ambulance services market on the basis of mode of transport, equipment, type of emergency, and geography. Ground ambulances, water ambulances, and air ambulances are the three modes of transport, with the segment of air ambulances holding the largest share of the market. Equipment-wise, the ambulance services market is categorized into advanced life support and basic life support. The market for advanced life support ambulances is a rapidly growing one, owing to high incidence of emergency cases. In comparison to non-emergency ambulance services, the market for emergency ambulance services is expected to expand at a higher rate in the forecasting horizon.
Geographically, Europe and North America collectively hold the highest share of the global ambulance services market. The presence of a huge pool of ambulance service providers makes these two markets strong players in the global ambulance services market. However, owing to high incidence of chronic diseases and growing geriatric population, the Asia Pacific market will witness robust growth in the years to come. Growing popularity of medical tourism in Thailand, Brazil, and India will drive the demand in the global ambulance services market during the forecast period.
Browse the full Ambulance Services Market (By Mode of Transport - Ground Ambulance Services, Air Ambulance Services and Water Ambulance Services, By Emergency Type - Emergency Ambulance Services and Non-Emergency Ambulance Services and By Equipment Type - Advance Life Support (ALS) Ambulance Services and Basic Life Support (BLS) Ambulance Services) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Press Release at http://www.transparencymarketresearch.com/pressrelease/ambulance-services-industry.htm

Sterilization Equipment and Disinfectants Market to Report Strong CAGR of 8.5% to reach US$ 9,153.9 Million by 2019

A new market study published by Transparency Market Research (TMR) presents a comprehensive analysis of the global sterilization equipment and disinfectants market. The market study talks about the current market situation and its impact on the future of the sterilization equipment and disinfectants market around the world. The report is titled “Sterilization Equipment and Disinfectants Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”.
Sterilization equipment and disinfectants are used to sterilize medical instruments, pharmaceutical components, and laboratory equipment. Sterilization equipment and disinfectants are essential components for infection control, as medical devices need sterilization and disinfection after being used, since they get contaminated with bioactive components.
The global market for sterilization equipment and disinfectants had reached a value of US$5.13 billion in 2012. It is estimated that the market will register a cumulative average growth rate of 8.5% during 2013 to 2019, and reach US$9.15 billion by 2019.
The market research report, inclusive of a detailed analysis of past performances, current trends, and future prospects of the global sterilization equipment and disinfectants market, makes for an informative and engaging piece of study.
The research report discusses the types and applications of sterilization equipment and disinfectants, in which sterilization equipment holds around 70% of the market based on revenue. The market for sterilization equipment is likely to rise at a 9.1% CAGR, which is expected to be the highest among all segments from 2013 to 2019. This development is credited to the user-friendliness and broad application area of the sterilization equipment market. In addition to this, sterilization equipment is safer to use than active disinfectants, which come with their own set of possible side-effects.
In 2012, the heat sterilization equipment market held the largest share on the basis of revenue in the total sterilization equipment market. It is likely to increase at an 8.6% CAGR from 2013 to 2019. This development is credited to the fact that heat sterilization equipment is more user-friendly and safer as compared to low-temperature sterilization equipment and others. However, low temperature sterilization is likely to register a growth at the highest, 10.9% CAGR during 2013 to 2019.
Browse the full Sterilization Equipment and Disinfectants Market (By Sterilization Equipment Type - Heat Sterilization, Low Temperature Sterilization, Filtration Sterilization and Radiation Sterilization,By Disinfectants Type-Low, Intermediate and High level and Oxidizing and Non-Oxidizing and By Applications- Medical Devices, Pharmaceuticals and Life-Sciences) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Press Release at http://www.transparencymarketresearch.com/pressrelease/sterilization-equipment-market.htm
Regionally, North America held the largest share of the global sterilization equipment and disinfectants market, holding more than 40% of the sterilization equipment and disinfectants industry in 2012. Increase in demand for non-disposable surgical devices such as distracters, endoscopy devices, and forceps are the growth drivers behind the rise of the sterilization equipment and disinfectants market in North America. Asia Pacific is the fastest developing sterilization equipment and disinfectants market, increasing at a 10.9% CAGR from 2013 to 2019.

Microscopy Devices Market will Thrive due to Increased Application in Nanotechnology

Exhaustive research and innovations in the field of microscopy have led to the growth of the global microscopy devices market, states Transparency Market Research in its latest report. The study, titled “Microscopy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020”, states that the microscopy devices market is poised to grow from US$5.75 billion in 2013 to US$9.69 billion by 2020. If these values hold true, the global microscopy devices market is forecast to register a CAGR of 7.6% from 2014 to 2020.The microscopy devices market is also fueled by the developing semiconductor industry in emerging countries and rising global funding toward nanotechnology. However, premium pricing has limited the penetration of advanced microscopes in developing countries. In addition, instrumentation and sample preparation complexities are likely to restrict the microscopy devices market.
On the basis of product, the global microscopy devices market is divided into electron microscopes, optical microscopes, scanning probe microscopes, and others. Optical microscopes held the largest share of the overall market in 2013, with 38.9%. This segment recorded global sales of US$2,235.1 million in 2013 and comprises stereo microscopes, inverted microscopes, fluorescence microscopes, phase contrast microscopes, near field scanning microscopes, and confocal scanning microscopes.Electron microscopes were the second largest product segment in 2013 and consist of scanning electron microscopes and transmission electron microscopes. The segment of scanning probe microscopes includes scanning tunneling microscopes and atomic force microscopes.
Based on application, the market for microscopy devices is segmented into life sciences, semiconductors, nanotechnology, material sciences, and others. Among these, the demand for microscopy devices from the life sciences industry enjoyed a majority share in 2013 and is anticipated to develop at a 6.4% CAGR from 2014 to 2020. While semiconductors formed the second largest application segment of the microscopy devices market, the segment of nanotechnology is expected to grow at the fastest CAGR of 12.4% during the forecast period.The global microscopy devices market is segmented on the basis of geography into North America, Europe, Asia Pacific, and Rest of the World. Accounting for 40.9% of the overall market, Asia Pacific emerged as the leader in the worldwide microscopy devices market in 2013. The growth of the Asia Pacific microscopy devices market can be attributed to the consistent research and development activities by several governments, universities, schools, and research institutions in the region. In fact, China is presently the second largest investor in R&D, according to the World Bank.
The prominent players participating in the global microscopy devices market include NT-MDT Company, FEI Company, Carl Zeiss AG, Leica Microsystems, Danish Micro Engineering A/S, Nikon Corporation, Bruker Corporation, JEOL Limited, Hitachi High-Technology Corporation, Cameca SAS, and Olympus Corporation. The competitive landscape of the microscopy devices market has been discussed at length, profiling major companies on the basis of business and financial overview, strategies, recent developments, and product portfolio.
Browse the full Microscopy Devices Market - Products (Optical Microscopes, Electron Microscopes, Scanning Probe Microscopes and Others) and Applications (Semiconductors, Life Sciences, Nanotechnology, Material Sciences and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 Press Release at http://www.transparencymarketresearch.com/pressrelease/microscopy-market.htm

Sunday 27 September 2015

Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022

Medical_Devices
According to a new market report published by Transparency Market Research “Non-invasive Prenatal Testing Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022”, the global NIPT market was valued at USD 0.53 billion in 2013 and is expected to expand at a CAGR of 17.5% from 2014 to 2022 to reach USD 2.38 billion in 2022.
Non-invasive prenatal diagnosis refers to screening test recommended for the detection of certain specific chromosomal aneuploidies from maternal blood sample. Over the past two years, the global prenatal testing market has witnessed a paradigm shift from conventional prenatal screening and diagnostic methods such as maternal serum screening, nuchal translucency (NT) scan, amniocentesis, and chorionic villus sampling (CVS) to non-invasive prenatal testing. This was mainly because of the advantages associated with NIPTs such as safety, accuracy, and no risk of miscarriage during the genetic screening test for common chromosomal abnormalities (trisomy 21, trisomy 18, trisomy 13, monosomy X, etc.). Currently, NIPTs are recommended only to high-risk pregnant women; however, several companies are targeting their tests toward both low-risk and high-risk pregnancies.
BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, and VisibiliT are the commercially available NIPTs in the global market. These tests are based on the direct analysis of cell-free fetal DNA in the maternal blood. MaterniT21 (MaterniT21 PLUS) was the first non-invasive prenatal Laboratory Developed Test (LDT) that was launched by Sequenom, Inc. in October 2011 for the detection of trisomy 21. MaterniT21 PLUS gained advantage of being the first mover in the NIPT market and was the most accepted NIPT in 2013, accounting for 36.1% share of the market in terms of revenue. It is likely to lose market share during the forecast period from 2014 to 2022 due to increasing market penetration by other NIPTs such as NIFTY, Panorama, and verifi.
In terms of volume, MaterniT21 test was the leading segment in 2013. However, the number of MaterniT21 tests performed would decrease during the forecast period from 2014 to 2022. This is majorly due to commercialization of other non-invasive tests and their positioning strategies. Due to the recent CFDA approval for BambniTest (Berry Genomics), the number of tests performed would increase during the forecast period.
Advantages offered by NIPT such as non-invasiveness, high accuracy and early detection; rising awareness, increasing market penetration in highly untapped countries in Europe and Asia; and continuous increase in average maternal age are the major factors expected to drive the growth of the global NIPT market during the forecast period. However, the market could face significant ethical and regulatory hurdles associated with the implementation of NIPT because of the belief that it is likely to increase the incidence of abortions. Therefore, various professional organizations such as the American College of Obstetricians and Gynecologists (ACOG), the International Society for Prenatal Diagnosis, the Japan Society of Obstetrics and Gynecology, and genetic counselors across the world have set up guidelines that limit the use of non-invasive prenatal testing only to pregnant women at high risk of chromosomal aneuploidies.
Several companies are investing in the development of non-invasive prenatal tests. Quest Diagnostics is developing a non-invasive test by utilizing the patented technology of Sequenom, Inc. and the test is likely to be commercialized in 2015. Sequenom, Inc., Illumina, Inc. (Verinata Health, Inc.), Ariosa Diagnostics, Natera, Inc., BGI Diagnostics, LifeCodexx AG, LabCorp, and Berry Genomics are the major companies operating in the global non-invasive prenatal tests market.
Browse the full Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, VisibiliT and Others) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022 Press Release at http://www.transparencymarketresearch.com/pressrelease/noninvasive-prenatal-diagnostics-market.htm
The global non-invasive prenatal testing market is segmented as follows:
Global Non-invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Test
  • BambniTest
  • Harmony
  • informaSeq
  • MaterniT21 PLUS
  • NIFTY
  • Panorama
  • PrenaTest
  • verifi
  • VisibiliT
Global Non-invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. 

Tuesday 22 September 2015

Platelet Aggregation Devices Market - Industry Research Report, 2015 - 2023

Platelet aggregation is a process where human platelet cells are involved in hemostasis, bleeding to repair, and vessel constriction. In addition, in conjunction with other cells they play a crucial role in the inflammation and other pathological situations. Platelet aggregation is a biological process which is mediated by a platelet activation factor (PAF). Platelet aggregation test involves venipuncture in an appropriate anti-coagulant medium, followed by centrifugation to produce plasma which is rich in platelets, where aggregometers are used to study the platelet aggregation. The inhibitory activity of the compounds is utilized for the assessment. Platelet function tests find application in pre-surgery tests; diagnose platelet dysfunction, monitoring anti-platelet therapy etc. Platelet aggregation is one of the various types of Platelet function tests. Platelet aggregation involves a set of medical devices, which allow precise control over the dynamic differential rate of blood flow control along with the extent of platelet thrombus formation.
The platelet aggregation devices market has been segmented based on device type, platelet function analyzer (PFA), aggregometers, platelet function centrifuge, platelet collection systems, and consumables & accessories. PFA is the most commonly used medical device for platelet aggregation. It is meant for aspirating in-vitro blood from the sample into cartridge test via a microscopic aperture, which is cut into biologically active collagen or epinephrine membrane on capillary ends. The PFA test reveals platelet function and number along with other specific elements. 
On the basis of end users, platelet aggregation devices market can be segmented into hospitals, diagnostic laboratories, medical research institutes and CROs, other end users (blood banks, companies engaged in clinical trials for platelet disorders). Geographically, North America (U.S and Canada) dominate the platelet aggregation devices market followed by Europe as leading manufacturers of platelet aggregation devices are domiciled in these regions having majority of their operations in local regional markets. However, Asia Pacific is also one of the key lucrative markets for these devices for diagnosing epidemic diseases such as Dengue, Malaria that affect a huge chunk of population in this region.
The potential drivers for this specialized and niche market includes massive unmet demand for platelet screening programs to identify diseases like HIV, Dengue etc. However, there is certainly a clear market demand among those undergoing anti-platelet therapy. On account of being a medical device market, the key forces for growth would depend upon product features such as precise control over the extent of platelet thrombus and spatial location, minimal blood sample volumes along with multiple clinical assessment’s, and simplified precise procedures. Besides, these factors Platelet Aggregation devices have a wide range of applications in diagnosing various diseases, detecting platelet dysfunction, and associated disorders. The demand for Platelet aggregation devices will be further spearheaded with a wide range of new applications such as assessment of surgical bleeding risk, identification of genetically acquired platelet defects etc. However, some of the restraints in this foresighted growth will be attributed to the high cost of purchase, limited usage, and limited scope at the level of end users. 
Some of the key players operating in the platelet aggregation devices market include Bio Data Corporation, Drucker Diagnostics, Haemonetics Corporation, Helena Laboratories, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings (LabCorp), Siemens Healthcare, Sienco, Inc., and Sysmex Corporation among others.

Global Report on Body Composition Analyzers Market

Body Composition Analyzers (BCA) helps in measuring different compounds present within the body and furnishing of their respective values at the point of analysis. Some of the analyzers can project cumulative variations in body composition for a specific period. Moreover, specific BCA can determine an individual’s risk of developing certain disease as truncal and abdominal obesity besides skin fold measurements can be used for risk factor analysis in cohort studies for obesity-induced diseases. These factors will promote the growth of BCA in the global market on account of its wide range of applications in the arena of sports, medical research, especially causal association research studies in the disciplines of anthropology, nutrition, epidemiology etc. However, largely BCA will be in demand from the sports, fitness, and wellness industry including gyms, fitness centers, wellness, and weight-management services.
BCA market can be segmented based on its technology, bioelectrical impedance analyzers which measures the impedance to the flow of an electric current through the body fluids contained mainly in the lean and fat tissue. There are other BCA technologies such as dual-energy X-ray absorptiometry for bone density analysis; Body Fat Calipers for anthropometric skin fold measurements, hydro densitometry, and Whole-body Air Displacement Plethysmography (ADP) for measuring mass per unit volume of human body.
The BCA market can also be segmented based on its application in the assessment of body composition such as total body hydration (extra-cellular and intra cellular, Total body and Visceral Fat percentage, lean muscle mass, Total skeletal muscle mass, comparative size of each limb, nutritional analysis and detailed Energy Expenditure (daily/weekly) information. Moreover, there are other advanced versions of BCA such as Direct Segmental Multi-frequency Bioelectrical Impedance Analysis (DSM-BIA) which categorically gives measurements for the impedance of the trunk, arms and legs.
Some of the potential drivers of this market include higher funding from government and global healthcare institutions like World health organization (WHO) for preventive healthcare practices. The provision for advanced level of health and fitness will boost revenues through referrals for engagement among members of a fitness club or gym that will draw motivation from each other’s experience. Therefore, BCA could be the next revenue generators in the health and wellness industry, which is increasing in leaps and bounds worldwide. BCA market has a tremendous scope in the sports industry where sports scientists, and sports authorities and centers along with personal instructors and specific sports training agencies are increasingly utilizing these analyzers. However, some of the restraints in this foresighted growth will be attributed to the high cost of these analyzers, and limited usage at the level of end users.
Globally, there is a heightened level of consciousness for fitness and personal grooming, as people lose weight, they might be increasing their muscle mass, however this will not be evident simply by weighing scales. There is boom in the fitness industry due to of potential growth in the BCA market can be related to this as there is a huge demand for prompt results, which are delivered by these BCA in gyms and fitness centers. Moreover, BCAs are expected to be in demand due to sedentary lifestyles and awareness about obesity and its related diseases, for instance animpedance and capacitive analyzer can produce individual centric values based on their age and ethnicity of the clinical population.
Some of the major players in the BCA market include AccuFitness, LLC, Beurer GmbH, Bodystat Ltd., GE Healthcare, Global Bodies,Hologic Inc., InBody Australia, Maltron International Ltd., Seca GmbH&Co. KG, and Tanita Corporation of America, Inc. among others.

Electronic Medical Records Market - Market Analysis Report, 2015 - 2023

An electronic medical record is a digital version of paper-based medical information of patients. Such electronic medical records are aimed at improving the overall quality of care. Electronic medical record comprises combination of clinical, financial, demographic and coded healthcare data. Many government organizations have also stressed upon the significance of electronic medical records. For instance, according to the World Health Organization, the proper collection, management and use of information within healthcare systems will determine the system’s effectiveness in detecting health problems, defining priorities, identifying innovative solutions and allocating resources to improve health outcomes. Currently, a number of hospitals and clinics are using electronic medical records to store important documents related to the patient’s illness. The information repository of individual patients would lead to better security and quick data retrieval whenever required.
Based on software delivery mode, the electronic medical records market can be segmented as follows:
Cloud: Cloud computing software allows centralized data storage and online access to services with multiple sites across geographic locations but do not support remote access to existing network. The software possesses the flexibility to allow anywhere and anytime access of data records.
On-premise: On-premises software, also known as shrink wrap, is installed and operated from the premises of the person or any organization. It makes use of the organization’s local computing resources and requires a licensed software copy from an independent software vendor
Based on end users, the electronic medical recordsmarket can be segmented as follows:
Hospitals
Clinics and nursing homes
Home health agencies
Geographically, the electronic medical recordsmarket can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). Out of these four regions, North America holds a leading position in the market followed by Europe. The prime factors driving the growth of the electronic medical recordsmarket in these regions are increased portability and accessibility of medical document management systems, and growing demand for paperless environment to minimize human error. Furthermore, technological advancement and modernization in the healthcare management system and improved clinical studies are also expected to augment the growth of the electronic medical records market in North America and Europe. Asia Pacific is one of the fastest growing regions globally and is expected to emerge as the most promising market for the growth of the electronic medical records market. The factors which would boost the growth of the market in Asia Pacific are growing demand for better quality of care, and increasing government initiatives to opt for patient flow management solution and electronic health records (EHRs). Moreover, better management of patient’s information record and increasing need to minimize records retention costs is also expected to accentuate the growth of the electronic medical recordsmarket in Asia Pacific.
Various companies offer novel systems and software for the management of health information. Such companies have simplified the complex medical records, hence achieving quality outcomes. Some of the top companies operating in the electronic medical recordsmarket are 3M Company, Toshiba Medical Systems Corp., Hyland Software, Siemens Medical Solutions, McKesson Corporation, Henry Schein, Inc., Allscripts Healthcare Solutions, Inc., WRS Health, Medical Information Technology, Inc. (Meditech), Cerner Corporation,Quest Diagnostics, GE Healthcare, Epic Systems, SequelMed, Kofax Limited and others. 

Extracorporeal Shock Wave Lithotripsy Market - Global Industry Analysis, Trends And Forecast 2015 - 2023

Extracorporeal shock wave lithotripsy (ESWL) is a most common non-invasive treatment for kidney stones and ureter stones. The lithotriptor applies external high-intensity acoustic pulse to crush the stone causing minimal damage to the normal tissue. The shock waves break the stones into small fragments. ESWL is widely used by physician worldwide due to characteristics such as non-invasiveness, reduced pain and recovery time and reduced hospital stay. The developing health care infrastructure by and availability of technically developed equipment to carry out the procedure are the vital drivers for the extracorporeal shock wave lithotripsy market. In addition, the rising prevalence and incidences of kidney stones and ureter stones are expected to fuel the extracorporeal shock wave lithotripsy market. Furthermore, the rising prevalence of obesity and patient awareness about the latest technological advancements will contribute to the growth of the market. However, failure of crushing large stones through ESWL is the challenging factor for the extracorporeal shock wave lithotripsy market.
The extracorporeal shock wave lithotripsy market can be segmented into technological, applications and end-user. Technologically, the market can be further segmented into electrohydraulic technique, piezoelectric technique, and electromagnetic technique. Electrohydraulic technique is the oldest and the original method of shockwave generation. Thus, it hold the largest share and is the most accepted technique in the extracorporeal shock wave lithotripsy by physicians and doctors. However, piezoelectric technique has the highest growth rate during the forecast period. On the basis of applications, the extracorporeal shock wave lithotripsy is used for kidney stones, uretic stones, pancreatic stones and salivary stones. Extracorporeal shock wave lithotripsy for kidney has the largest market share and continue to show uniform growth during the forecast period. Depending on the end-user, extracorporeal shock wave lithotripsy is segmented into hospitals, clinics, radiology labs and others. Hospitals held the largest share in the extracorporeal shock wave lithotripsy market by end-user. However, the growth of clinic providing extracorporeal shock wave lithotripsy is boosting due to technological growth and reduced recovery time and early discharge after the treatment.
Geographically, North America held the largest share in the extracorporeal shock wave lithotripsy throughout the forecast period. Presence of large number of obese patients susceptible to the development of kidney stones is expected to surge the market. Investment in medical device technology research and development have coursed in the recent past as well as collaborations have led to recent advances in the technique. Europe is the second largest extracorporeal shock wave lithotripsy market due to increased government investment fueling the market growth. However, the fastest growing region is expected to be Asia Pacific due to emerging health care infrastructure, and development of technological facilities. Rising population, changing lifestyle and high acceptance to novel technology are the major market drivers in this region. Japan, China and India are the fastest growing economies in Asia Pacific. South American countries such as Brazil and Mexico are the regions that have significant potential for growth due to developing medical infrastructure, and high disposable income. 
Globally, the extracorporeal shock wave lithotripsy market is dominated by players such as Boston Scientific Corporation, C.R. Bard Inc., Lumenis LTD, Cook Group Inc., Siemens AG, Medtrue Enterprise Co. Ltd., Karl Storz Gmbh and Co. KG, Olympus Corporation, Sainty Pharma, and Dornier MedTech GmbH.

Leukemia Therapeutics Market - Industry Research Report, 2015 - 2023

Leukemia is a type of blood cancer resulting in the abnormal production of blood cells, generally leukocytes (white blood cells). These abnormal cells crowd the bone marrow and other organs such as liver, spleen, and kidneys through blood and prevent its normal functions. There are several types of leukemia that appear suddenly and progress rapidly over days to weeks. Others are less apparent and progress slowly over months to years. Leukemia are named according to the type of blood cells involved. The myeloid leukemia are the ones which involve the granulocytes, red blood cells, platelets, and monocytes and lymphocytic leukemia are those which involve lymphocytes. Leukemia is commonly caused due to the high exposure to radiations, unhealthy lifestyle, genetic factors, and environmental conditions. Leukemia cases are more common in adults and are observed to progress with aging. Thus, increasing geriatric population base and high prevalence of leukemia are the factors driving the leukemia therapeutic market. Moreover, increased innovation and R&D in the oncology sectors and growing number of biotechnology firms are also expected to propel the market growth. Increasing awareness of patients regarding most recent technological developments, introduction of novel therapies and promising pipeline products are the factors expected to further drive the market growth during the forecast period. However, high cost of drugs and treatments along with large number of entry-to-market barriers are some of the challenges faced by the leukemia therapeutic market.
Leukemia therapeutics market can be segmented on the basis of the disease condition, treatment and drugs. Leukemia therapeutic market includes disease such as acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. Chronic myeloid leukemia dominated the overall leukemia therapeutic market owing to high prevalence rate in 2014. Treatment segment includes chemotherapy, radiation therapy, immunotherapy, surgery, targeted therapy, bone marrow transplant, and stem cell therapy. Radiation therapy and chemotherapy treatments were the most popularly used methods for the treatment of leukemia. Chemotherapy is the standard treatment for many types of leukemia. Targeted therapies are a newer forms of cancer treatment that can be used together with chemotherapy or unavailability of other therapies. Stem cell therapy and bone marrow transplant are the emerging trends in leukemia therapeutic market and are expected to boost the market growth. Drugs used for treating leukemia can be classified according to the classes which include kinase inhibiting drugs such as imatinib (Gleevec), dasanib (Sprycel), erlotinib (Tarceva), and gefitinib (Iressa); aminopeptidase inhibitors like Tosedostat; and immunomodulatory drug class (IMiDs) such as lenalidomide (Revlimid) and others. Sapacitabine, GA101 (Obinutuzunab), fludarabine and cyclophosphamide are some promising drugs in the clinical trials.
Geographically, North America accounts for the largest regional market, followed by Europe due to the increasing patient awareness, technological advancement, supportive government policies in terms of incentives and investments, and refined healthcare infrastructure. According to the World Health Organization (WHO), leukemia is expected to be more prominent in the developed world such as North America and Europe due to genetic factors caused by enhanced radiation exposure. Environmental factors and unhealthy lifestyles are the factors which add to the count. Similarly, the market is expected to grow promptly due to presence of high unmet needs in the emerging countries of Asia Pacific such as China, India, and Japan. Increasing investments in R&D expenditures by biotechnology firms, rapidly improving health care infrastructure, and growing awareness levels are the factors promoting the market growth in Asia Pacific. Countries of South America countries such as Brazil and Mexico are expected to have significant growth potential due to developing medical infrastructure, high disposable income, and rising prevalence of leukemia.
Some of the prominent market players operating in the global leukemia therapeutics market are Novartis AG, F. Hoffmann-La Roche AG, Bristol Myers Squibb Company (BMS), GlaxoSmithKline plc, Pfizer, Inc., Celgene Corporation, Biogen, Genzyme Corporation, and Eisai Co. Ltd.

Guidewires Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2015 - 2023

A guidewire is a thin and flexible tube used to guide a catheter for placement in the diseased artery. The catheter is advanced through a guidewire into the blood vessel, then guided to aorta and finally, the guidewire is removed. The most frequent insertion point for the guidewire and catheter is the femoral artery at the groin. Apart from this, other possible insertion points for guidewires include brachial artery and coronary arteries. With the increase in the number of minimally invasive procedures, the demand for guidewires is expected to increase in the next few years. Most guidewires are manufactured from low cost stainless steel with an elastic coil tip to avoid damage to the blood vessels. These guidewires are reusable in nature; hence most manufacturers prefer low cost stainless steel as the choice of raw material. A number of companies offer a robust range of tip shapes and wire configurations making it possible for healthcare experts to choose the right tool for surgical procedures. The usage of guidewiresis growing rapidly in the medical device industry due to its biomechanical properties. Additionally, the demand for guidewires is being fueled by rising patient awareness about the benefits of minimally invasive procedures such as less traumatic surgical experience, reduced hospital stay, and faster recovery.
Based on types, the guidewires market has been segmented into the following:
Peripheral guidewire
Coronary guidewire
Neurovascular guidewire
Urology guidewire
Geographically, the guidewires market can be segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). North America holds a leading position in the guidewires market followed by Europe. The major driving factors for the growth of the guidewires market in these regions arerise in geriatric population, and growing lifestyle diseases. Additionally, increasing demand for minimally invasive surgeries, unique biomechanical properties of guidewires, and growing inclination of healthcare professionals toward the usage of efficient medical devices are some of the factors expected to drive the market growth during the forecast period. Hence, all these factors are collectively driving the demand for medical guidewires. Asia Pacific is one of the most lucrative markets for the growth of guidewires market and is developing at a rapid rate. The factors which would accentuate the growth this market in Asia Pacific are presence of a large pool of patients suffering from peripheral vascular diseases which would consequently lead to an increase in the volume of endovascular procedures in densely populated countries such as India and China. Furthermore, economic development, improving healthcare facilitiesrising disposable incomes, and government initiatives in countries such as China and Indiaprovide a large base of patient population with access to healthcare facilities at an affordable rate.
Various medical devices companies are constantly trying to come up with novel guidewires for different medical procedures. Technological innovation and advancements across various type of guidewires, in terms of flexibility, construction, and tip retention are few of the factors to be considered while manufacturing medical guidewires. Some of the top major players operating in the guidewires market are Boston Scientific Corporation, Cordis Corporation, C.R. Bard, Inc., ASAHI INTECC, Terumo Corporation, Covidienplc, Medtronic, Inc., Abbott Laboratories, B. Braun Melsungen AG, and Cook Medical.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of 
Market growth drivers 
Factors limiting market growth
Current market trends 
Market structure
Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.